[1]
A. R. Alvarez Crespo, L. Alonso Carbonell, I. B. Yara Alos, A. J. Garcia Milian, and M. A. Marrero Miragaya, “Characterization of adverse events during the treatment with heberprot-p® in four cuban provinces”, HS, vol. 14, no. 2, pp. 42–46, Sep. 2015, doi: 10.19136/hs.a14n2.950.